All Sauce from Weekly Sauce:

A new drug combination for advanced liver cancer can extend people’s lives substantially more than the long-standing drug of choice, new study findings confirm. The treatment involves two drugs approved to fight various cancers: bevacizumab (Avastin) and atezolizumab (Tecentriq). Avastin, an intravenous (IV) drug, starves tumors by preventing new blood vessel growth. Tecentriq, also given…  read on >  read on >

Children in day care centers had low coronavirus infection rates early in the pandemic, and are unlikely sources of COVID-19 transmission, a new study from France finds. COVID-19 can infect people of all ages, but children tend to develop mild, if any, symptoms, and very rarely need to be hospitalized. Very young children’s role as…  read on >  read on >